Rights & Issues Investment Trust Ord (RIII)

Category UK Small-Cap Equity

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.

Sell

2,320.00p

Buy

2,400.00p

arrow-down-40.00p (-1.69%)

Discount/Premium

-5.45%

Estimated NAV

2,496.13p

Prices updated at 07 Jan 2025, 18:13 GMT

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The objective is to exceed the benchmark index over the long term whilst managing risk. The Company invests in equities with an emphasis on smaller companies. UK smaller companies will normally constitute at least 80% of the investment portfolio. UK smaller companies include both listed securities and those quoted on the Alternative Investment Market.

FTSE All-Share

-0.22%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Company name

Jupiter Unit Trust Managers Ltd

Legal structure

Closed Ended Investment Company

Domicile

United Kingdom

Fiscal year end

31 Dec 2025

Launch date

31 Jul 1962

Lead manager

Matthew Cable

Lead manager start date

03 Oct 2022

Lead fund manager biography

Matt is an Investment Manager in the UK Small & Mid Cap Equities team. Before joining Jupiter, Matt worked at M&G for 11 years, during which time he was a member of the smaller companies team, and was involved in the running of c. £850m of assets. He began his investment career in 2001. Matt has a degree in pharmacology and is a CFA® charterholder.

Head office

The Zig Zag Building

70 Victoria Street

London

United Kingdom

SW1E 6SQ

+44 20 3817 1000

Company website

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.